| Literature DB >> 29788872 |
Qi Zhang1, Sudan Wang1, Ruirui Qiao2, Michael R Whittaker2, John F Quinn2, Thomas P Davis2,3, Hongjun Li1.
Abstract
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, leading to the second most likely cause of cancer-related deaths. Medical imaging is crucial in clinic for HCC screening and diagnosis. Due to the relatively high special resolution and excellent sensitivity, magnetic resonance imaging (MRI) by using magnetic nanoparticle-based contrast agents has been used so far in HCC imaging and staging, demonstrating great potential and promising in vivo applications. This review focuses on the use of different magnetic nanoparticles for construction of HCC nanoprobes for MR imaging and theranostic purpose. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.Entities:
Keywords: MRI; Magnetic nanoparticle; cancer; diagnosis; hepatocellular carcinoma; molecular imaging.
Mesh:
Substances:
Year: 2018 PMID: 29788872 DOI: 10.2174/1381612824666180516111939
Source DB: PubMed Journal: Curr Pharm Des ISSN: 1381-6128 Impact factor: 3.116